natgillin/translations-raw huggingface dataset:
• oral contraceptives (birth control pills) 
• danazol (zdravilo, ki se uporablja za zdravljenje endometrioze), • peroralne kontraceptive (tablete za preprečevanje zanositve),
Pack sizes of 1 (with or without needles), 2 (without needles), 3 (without needles), 5 (without needles) and multipack containing 6 (2 packs of 3) (without needles) pre-filled pens. 
Pakiranja z 1 (z iglami ali brez), 2 (brez igel), s 3 (brez igel) ali s 5 (brez igel) in skupno pakiranje s 6 (2 škatli po 3, brez igel) napolnjenimi injekcijskimi peresniki.
Hypoglycaemia (too low blood sugar) may occur very commonly with insulin treatment (may affect more than 1 in 10 people). 
Hipoglikemija (prenizek krvni sladkor) je zelo pogost neželeni učinek pri zdravljenju z insulinom
The pen can dial up to a maximum of 160 units. 
Z injekcijskim peresnikom lahko izberete največ 160 enot.
NAME OF THE MEDICINAL PRODUCT Tresiba 100 units/mL solution for injection in pre-filled pen Tresiba 200 units/mL solution for injection in pre-filled pen Tresiba 100 units/mL solution for injection in cartridge 
Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku Tresiba 200 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku
What Tresiba looks like and contents of the pack Tresiba is presented as a clear and colourless solution for injection in a pre-filled pen (600 units per 3 mL). 
Zdravilo Tresiba je na voljo kot bistra in brezbarvna raztopina za injiciranje v napolnjenem injekcijskem peresniku (600 enot v 3 ml).
• Always keep your pen with you. 
• Injekcijski peresnik vedno nosite s seboj.
• Check the name and strength on the label of your pen to make sure that it contains Tresiba 200 units/mL. 
• Preverite ime in jakost na nalepki injekcijskega peresnika, da se prepričate, da res vsebuje zdravilo Tresiba 200 enot/ml.
Tresiba 100 units/mL solution for injection in pre-filled pen Tresiba 100 units/mL packaging and label are light green. 
Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku Škatla in nalepka zdravila Tresiba 100 enot/ml sta svetlo zelene barve.
Caution: One step equals 2 units - the pen shows the dose 
Pozor: En odmerni korak predstavlja 2 enoti.
6 units selected 
izbranih 6 enot primera izbranih 24 enot
4 Confirmed hypoglycaemia was defined as episodes confirmed by plasma glucose <3.1 mmol/L or by the patient needing third party assistance. 
4 Potrjena hipoglikemija je bila opredeljena kot potrjena koncentracija glukoze v plazmi < 3,1 mmol/l ali potreba po pomoči druge osebe.
For both strengths, the needed dose is dialled in units. 
Zdravilo Tresiba je na voljo v dveh jakostih in pri obeh se potrebni odmerek meri v enotah.
1 In a once-daily regimen + insulin aspart to cover mealtime insulin requirements 2 In a once-daily regimen ± OADs (any combination of metformin, dipeptidyl peptidase-4 inhibitor, alpha-glucosidase inhibitor, thiazolidinediones, and sodium glucose cotransporter-2 inhibitor) 3 Per patient year of exposure 
1 Shema enkrat na dan + insulin aspart za kritje potreb po insulinu ob obrokih ± metformin ± pioglitazon 2 Shema enkrat na dan ± metformin, sulfonilsečnina/glinid ± pioglitazon 3 Potrjena hipoglikemija je bila opredeljena kot potrjena koncentracija glukoze v plazmi < 3,1 mmol/l ali potreba po pomoči druge osebe.
Each pre-filled pen contains 300 units of insulin degludec in 3 mL solution. 
En napolnjen injekcijski peresnik vsebuje 300 enot insulina degludek v 3 ml raztopine.
Keep the cap on the pen in order to protect from light. 
Vložke shranjujte v škatli za zagotovitev zaščite pred svetlobo.
2 Confirmed hypoglycaemia was defined as episodes confirmed by plasma glucose <3.1 mmol/L or by the patient needing third party assistance. 
2 Potrjena hipoglikemija je bila opredeljena kot potrjena koncentracija glukoze v plazmi < 3,1 mmol/l ali potreba po pomoči druge osebe.
This makes sure that the insulin flows. 
To zagotavlja pretok raztopine.
Table 2 Hypoglycaemia meta-analysis outcomes 
Izidi metaanalize hipoglikemij
Instructions on how to use Tresiba 200 units/mL solution for injection in pre-filled pen (FlexTouch) 
Navodila za uporabo zdravila Tresiba 200 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku (FlexTouch)
Table 4 Results from open-label clinical trials in insulin naïve type 2 diabetes mellitus (insulin initiation) 
Rezultati odprtih kliničnih preskušanj pri bolnikih s sladkorno boleznijo tipa 2, ki še niso prejemali insulina (uvedba insulinskega zdravljenja)
Instructions on how to use Tresiba 100 units/mL solution for injection in pre-filled pen (FlexTouch) 
Navodila za uporabo zdravila Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku (FlexTouch)
• Measure your blood sugar if possible and rest. You may need to measure your blood sugar more than once, as with all basal insulin products improvement from the period of low blood sugar may be delayed. 
Meritve boste morda morali ponoviti večkrat, saj do izboljšanja lahko pride z zakasnitvijo, kot pri uporabi vseh zdravil z bazalnim insulinom.
• The dose counter shows the dose dialled in units. 
Izbirnik odmerka kaže odmerek v enotah, ne glede na koncentracijo zdravila.
Tresiba 100 units/mL solution for injection in pre-filled pen Solution for injection (FlexTouch). 
Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku raztopina za injiciranje (FlexTouch)
Insulin glargine (100 units/mL)1 
insulin glargin (100 enot/ml)1
Insulin glargine (100 units/mL)2 
insulin glargin (100 enot/ml)2
Tresiba 200 units/mL solution for injection in pre-filled pen Solution for injection (FlexTouch). 
Tresiba 200 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku raztopina za injiciranje (FlexTouch)
• angiotensin converting enzyme (ACE) inhibitors, for some heart problems or high blood pressure. 
• zaviralce angiotenzinske konvertaze (zaviralce ACE (angiotensin converting enzyme))
• Check the name and strength on the label to make sure it is Tresiba 100 units/mL. 
• Preverite ime in jakost na nalepki, da se prepričate, da imate res zdravilo Tresiba 100 enot/ml.
The dose counter shows the number of units regardless of strength and no dose conversion should be done when transferring a patient to a new strength. 
Zato se pri prehodu bolnika na drugačno koncentracijo zdravila ne sme pretvarjati enot.
• Check the name and strength on the label of your pen to make sure that it contains Tresiba 100 units/mL. 
• Preverite ime in jakost na nalepki injekcijskega peresnika, da se prepričate, da res vsebuje zdravilo Tresiba 100 enot/ml.
Favours Tresiba 
V prid zdravilu Tresiba
Each cartridge contains 300 units of insulin degludec of insulin in 3 ml solution. 
En injekcijski vložek vsebuje 300 enot insulina degludek v 3 ml raztopine.
Pack sizes of 1 (with or without needles), 2 (without needles), 3 (without needles), 5 (without needles) and multipack of 6 (2 x 3) (without needles) pre-filled pens of 3 mL. 
Pakiranja z 1 (z iglami ali brez), 2 (brez igel), s 3 (brez igel) ali s 5 (brez igel) in skupno pakiranje s 6 (2 x 3, brez igel) napolnjenimi injekcijskimi peresniki po 3 ml. Na trgu morda ni vseh navedenih pakiranj.
Pack sizes of 1 (with or without needles), 5 (without needles) and multipack containing 10 (2 packs of 5) (without needles) pre-filled pens. 
Pakiranja z 1 (z iglami ali brez), s 5 (brez igel) in skupno pakiranje z 10 (2 škatli po 5, brez igel) napolnjenimi injekcijskimi peresniki.
Type 2 diabetes mellitus Maintenance period b 
Vzdrževalno obdobje b
• Never share your pen with other people. 
• Injekcijskega peresnika si ne smete deliti z drugimi.
INFORMATION IN BRAILLE Tresiba pre-filled pen 100 units/mL 
Tresiba peresnik 100 enot/ml
Dose selector Dose button 
FlexTouch potisni gumb z 2
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (100 units/mL cartridge (Penfill)) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (Injekcijski vložek 100 enot/ml (Penfill))
Clear, colourless, neutral solution. 
Uporabite le bistro, brezbarvno raztopino.
Injection site reactions Uncommon Peripheral oedema 
Bolezni imunskega sistema redki preobčutljivost urtikarija
Tresiba 100 units/mL solution for injection in cartridge insulin degludec 
Tresiba 100 enot/ml raztopina za injiciranje insulin degludek
Tresiba 100 units/mL solution for injection in cartridge 3 mL solution in a cartridge (type 1 glass) with a plunger (halobutyl) and a laminate rubber sheet (halobutyl/polyisoprene) in a carton. 
3 ml raztopine v injekcijskem vložku (steklo tipa 1) z batom (halobutil) in plastjo laminirane gume (halobutil/poliizopren) v škatli.
Table 3 Results from open-label clinical trials in type 1 diabetes mellitus 52 weeks of treatment 
Rezultati odprtih kliničnih preskušanj pri sladkorni bolezni tipa 1
STATEMENT OF ACTIVE SUBSTANCE One cartridge contains 300 units of insulin degludec in 3 mL solution 1 mL solution contains 100 units of insulin degludec (equivalent to 3.66 mg) 
1 ml raztopine vsebuje 100 enot insulina degludek (kar ustreza 3,66 mg),
Tresiba 200 units/mL solution for injection in pre-filled pen 3 mL solution in a cartridge (type 1 glass) with a plunger (halobutyl) and a laminate rubber sheet (halobutyl/polyisoprene) contained in a pre-filled multidose disposable pen made of polypropylene. 
Tresiba 200 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku 3 ml raztopine v injekcijskem vložku (steklo tipa 1) z batom (halobutil) in plastjo laminirane gume
STATEMENT OF ACTIVE SUBSTANCE One pre-filled pen contains 600 units of insulin degludec in 3 mL solution 1 mL solution contains 200 units of insulin degludec (equivalent to 7.32 mg) 
1 ml raztopine vsebuje 200 enot insulina degludek (kar ustreza 7,32 mg),
Basal only therapy in previously insulin-naïve 
Samo bazalno zdravljenje pri bolnikih, ki še niso prejemali insulina
Difference: -0.13 [-0.29; 0.03] 
Razlika: -0,13 [-0,29; 0,03] 5
Always keep the cap on the pen when you are not using it in order to protect it from light. 
Kadar injekcijskega peresnika ne uporabljate, naj bo vedno pokrit s pokrovčkom za zagotovitev zaščite pred svetlobo.
MARKETING AUTHORISATION NUMBER EU/1/12/807/005 10 pens of 3 mL 
EU/1/12/807/005 10 injekcijskih peresnikov s 3 ml
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS LABEL (100 units/mL cartridge (Penfill)) 
NALEPKA (Injekcijski vložek 100 enot/ml (Penfill))
MARKETING AUTHORISATION NUMBER EU/1/12/807/015 6 pens of 3 mL 
EU/1/12/807/015 6 injekcijskih peresnikov s 3 ml
1 Once-daily regimen + insulin aspart to cover mealtime insulin requirements ± metformin ± pioglitazone 2 Once-daily regimen ± metformin SU/glinide ± pioglitazone 
1 Shema enkrat na dan + insulin aspart za kritje potreb po insulinu ob obrokih.
Eye disorder 
Očesne bolezni
Tresiba 200 units/mL solution for injection in pre-filled pen insulin degludec 
Tresiba 200 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin degludek
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (200 units/mL pre-filled pen (FlexTouch)) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (Napolnjen injekcijski peresnik 200 enot/ml (FlexTouch))
NAME OF THE MEDICINAL PRODUCT Tresiba 200 units/mL solution for injection in pre-filled pen insulin degludec 
Navodilo za uporabo Tresiba 200 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin degludek
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (100 units/mL pre-filled pen (FlexTouch)) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (Napolnjen injekcijski peresnik 100 enot/ml (FlexTouch))
The dose is provided in half the volume of 100 units/mL basal insulin products. 
Odmerek se injicira v polovičnem volumnu raztopine v primerjavi z ostalimi bazalnimi insulinskimi zdravili s koncentracijo 100 enot/ml.
Pen label Dose counter Dose pointer 
pokrovček peresnika zunanji pokrovček igle notranji pokrovček igle igla papirna nalepka merilo preostanka insulina insulinsko okence nalepka injekcijskega peresnika števec odmerka kazalnik odmerka izbirnik odmerka potisni gumb
Important information about some of the ingredients of Tresiba This medicine contains less than 1 mmol sodium (23 mg) per dose. 
Natrij To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija'.
Needle 
Huda
Nocturnal confirmed hypoglycaemia was defined as episodes between midnight and 6 a.m. 5 The difference is for Tresiba Flex - Tresiba 
5 To je razlika med Tresiba Flex - Tresiba.
Results support the use of Tresiba in adolescent patients with type 2 diabetes mellitus. 
Uporaba zdravila Tresiba v kombinaciji z agonisti receptorjev GLP-1 pri bolnikih s sladkorno boleznijo tipa 2
The Poster for pharmacies/diabetic units shall contain the following key elements: - That Tresiba is available in 2 strengths; - Key differences in the design of the packages and the pre-filled pen devices; - When prescribing to make sure that the correct strength is mentioned in the prescription slip; - Always check the insulin label before dispensing to make sure the correct strength is delivered to the patient; - Always check the insulin label before each injection to avoid accidental mix-ups between the two different strengths of Tresiba; - Do not use outside of the pre-filled pen device (e.g. syringes); - Reporting of medication errors or any side effects. 
V primeru poslabšanja vida se posvetujte z zdravnikom; • uporabo pravega insulina; pred injiciranjem vedno preverite nalepko insulina, da po pomoti ne zamenjate dveh različnih jakosti zdravila Tresiba, kot tudi drugih insulinskih zdravil.
NAME OF THE MEDICINAL PRODUCT Tresiba 100 units/mL solution for injection in cartridge insulin degludec 
Navodilo za uporabo Tresiba 100 enot/ml raztopina za injiciranje v injekcijskem vložku insulin degludek
Tresiba 100 units/mL solution for injection in pre-filled pen insulin degludec 
Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin degludek
Initiation 
Nosečnost
Based on your blood sugar level, your doctor may change your dose. 
Zdravnik vam odmerek lahko spremeni glede na koncentracijo krvnega sladkorja.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACK LABEL (100 units/mL pre-filled pen (FlexTouch)) 
NALEPKA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 100 enot/ml (FlexTouch))
PARTICULARS TO APPEAR ON THE INNER PACKAGING CARTON FOR MULTIPACK (200 units/mL pre-filled pen (FlexTouch)) 
PODATKI, KI MORAJO BITI NAVEDENI NA STIČNIH OVOJNINAH ŠKATLA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 200 enot/ml (FlexTouch))
PARTICULARS TO APPEAR ON THE INNER PACKAGING CARTON FOR MULTIPACK (100 units/mL pre-filled pen (FlexTouch)) 
PODATKI, KI MORAJO BITI NAVEDENI NA STIČNIH OVOJNINAH ŠKATLA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 100 enot/ml (FlexTouch))
PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACK LABEL (200 units/mL pre-filled pen (FlexTouch)) 
NALEPKA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 200 enot/ml (FlexTouch))
NAME OF THE MEDICINAL PRODUCT Tresiba 100 units/mL solution for injection in pre-filled pen insulin degludec 
Navodilo za uporabo Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin degludek
Start by checking your pen to make sure that it contains Tresiba 200 units/mL, then look at the illustrations below to get to know the different parts of your pen and needle. 
Začnite tako, da preverite injekcijski peresnik in se tako prepričate, da vsebuje zdravilo Tresiba 200 enot/ml.
• If severe low blood sugar is not treated over time, it can cause brain damage. 
• Nezdravljeno hudo znižanje krvnega sladkorja lahko povzroči (prehodno ali trajno) okvaro možganov ali celo smrt.
Tresiba 200 units/mL solution for injection in pre-filled pen 
Tresiba 100 enot/ml raztopina za injiciranje v injekcijskem vložku
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Tresiba 200 units/mL solution for injection insulin degludec 
Tresiba 200 enot/ml raztopina za injiciranje insulin degludek
Pack sizes of 1 (with or without needles), 5 (without needles) and multipack of 10 (2 x 5) (without needles) pre-filled pens of 3 mL. 
Pakiranja z 1 (z iglami ali brez), s 5 (brez igel) in skupno pakiranje z 10 (2 x 5, brez igel) napolnjenimi injekcijskimi peresniki po 3 ml. Na trgu morda ni vseh navedenih pakiranj.
• thyroid hormones, for thyroid problems 
• ščitnične hormone (uporabljajo se za zdravljenje motenj v delovanju žleze ščitnice),
INFORMATION IN BRAILLE Tresiba cartridge 100 
Tresiba vložek 100
This may lead to too high blood sugar level. 
Je lahko zelo nevarna, saj se lahko v primeru zelo nizkega krvnega sladkorja onesvestite.
Close glucose monitoring is recommended during the transfer and in the following weeks. 
Ob prehodu ter nekaj tednov po njem je priporočljivo skrbno spremljanje koncentracije glukoze v krvi.
(sinusitis), o inflamed nose or throat (nasopharyngitis) (signs of this may include a cold or a sore throat). 
Pogosti - okužba spolovil (gobice) na spolnem udu ali v nožnici (med znaki so lahko draženje, srbenje,
< 8.0% ≥ 8% to < 9.0% ≥ 9.0% 
< 8,0 % ≥ 8 % do < 9,0 % ≥ 9,0 %
The recommended dose is two tablets once a day. 
Priporočeni odmerek sta dve tableti enkrat na dan.
Your blood sugar may rise without this medicine. 
Krvni sladkor se vam lahko brez tega zdravila zviša.
Possible signs of dehydration are listed in section 4. 
Možni znaki dehidracije so navedeni v poglavju 4.
(when used with SU) 
(v primeru uporabe s SU)
Take the tablets at around the same time each day. 
- Tablete jemljite približno vsak dan ob istem času.
The requirements for submission of PSURs for this medicinal product are set out in the list of Union references dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal. 
Zahteve glede predložitve PSUR za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
Take your tablets with food. 
- Tablete vzemite s hrano.
Do not store above 30°C. 
Shranjujte pri temperaturi do 30 °C
In both cases, treatment with Qtrilmet may be restarted once the patient's condition has stabilised. 
V obeh primerih se sme zdravljenje z zdravilom Qtrilmet znova začeti, ko se bolnikovo stanje stabilizira.
Fournier's gangrene has to be treated immediately. 
Fournierjeva gangrena zahteva takojšnje zdravljenje.
If pregnancy is detected, treatment with this medicinal product should be discontinued. 
Če je ugotovljena nosečnost, je treba zdravljenje s tem zdravilom prenehati.
This is to reduce the risk of side effects on the stomach. 
Tako boste zmanjšali tveganje za neželene učinke na želodec.
Randomised and treated patients. 
Randomizirani in zdravljeni bolniki.
A GFR should be assessed before initiation of treatment with metformin containing medicinal products and at least annually thereafter. 
GFR je treba oceniti pred začetkom zdravljenja z zdravili, ki vsebujejo metformin, potem pa vsaj enkrat na leto.
This is normal and what is left of the tablet after all the medicine has been released. 
To je normalno; ovojnica je tisto, kar ostane od tablete, ko se vse zdravilo sprosti.
Lactic acidosis is a medical emergency and must be treated in a hospital. 
Laktacidoza je nujno stanje, ki ga je treba zdraviti v bolnišnici.
The efficacy and safety profiles of Qtrilmet in these patients have not been established. 
Profila učinkovitosti in varnosti zdravila Qtrilmet pri teh bolnikih nista ugotovljena.
Consideration of such etiology is recommended if a patient presents with megaloblastic anaemia. 
Možnost takšne etiologije je treba upoštevati, če se bolniku pojavi megaloblastna anemija.
No benefit was observed for MACE or all-cause mortality. 
Opažali niso nobene koristi niti glede MACE niti glede umrljivosti zaradi vseh vzrokov.
Like for all diabetic patients it is important to counsel patients on routine preventative foot care. 
Kot pri vseh bolnikih s sladkorno boleznijo je pomembno bolnikom svetovati glede redne preventivne nege stopal.
Your kidney function will be checked at least once every year or more frequently if you are elderly or if you have worsening kidney function. 
Delovanje ledvic vam bodo preverjali vsaj enkrat na leto, lahko pa še pogosteje, če ste starejša oseba ali se vam delovanje ledvic slabša.
To avoid overdose, do not continue taking the separate tablets of these medicines as well as Qtrilmet. 
Da bi preprečili preveliko odmerjanje, ne nadaljujte jemanja ločenih tablet teh zdravil hkrati z zdravilom Qtrilmet.
This leads to a high level of sugar (glucose) in your blood. 
To povzroči visoko koncentracijo sladkorja (glukoze) v krvi.
Periodic safety update reports (PSURs) 
• Redno posodobljena poročila o varnosti zdravila (PSUR)
The numerical imbalance of breast, bladder, and prostate tumours must be considered with caution; it will be further investigated in post-authorisation studies. 
Številsko neravnovesje pri tumorjih dojke, sečnega mehurja in prostate je treba tolmačiti previdno; to bo dodatno raziskano v študijah po izdaji dovoljenja za promet z zdravilom.
Occasionally, the inactive ingredients of this medicine will be eliminated in the faeces as a soft, hydrated mass that may resemble the original tablet. 
Včasih se lahko neaktivne sestavine tega zdravila izločijo v blatu kot mehka, hidrirana masa, ki je lahko podobna originalni tableti.
Swallow the tablets whole with half a glass of water. 
Jemanje tega zdravila - Tablete zaužijte cele s pol kozarca vode.
o film-coating: 
o Filmska obloga:
Generally, the most common adverse events reported in ≥ 65 years old were similar to < 65 years old. 
Na splošno so bili najpogostejši neželeni učinki, ki so bili zabeleženi pri osebah, starih ≥ 65 let, podobni kot pri osebah, starih < 65 let.
Saxagliptin: Elderly patients (65-80 years) had about 60% higher saxagliptin AUC than young patients (18-40 years). 
Saksagliptin: Starejši bolniki (65-80 let) so imeli vrednost AUC saksagliptina približno 60 % večjo kot mladi bolniki (18-40 let).
The mean Vd ranged between 63-276 L. 
Povprečni Vd je od 63 do 276 l.
The remaining 219 patients started to take 5 mg saxagliptin 16 weeks ahead of the study start. 
Preostalih 219 bolnikov je začelo jemati 5 mg saksagliptina 16 tednov pred začetkom študije.
The dose should be taken as two tablets orally, once daily at the same time of the day, with food. 
Odmerek morajo vzeti kot dve tableti, peroralno, enkrat na dan in vedno ob istem dnevnem času, skupaj s hrano.
A limited amount of data from the use of metformin in pregnant women does not indicate an increased risk of congenital malformations. 
Maloštevilni podatki o uporabi metformina pri nosečnicah ne kažejo večjega tveganja za prirojene malformacije.
Proportion of patients achieving HbA1c < 7% 
Delež bolnikov, ki so dosegli HbA1c < 7 %
Talk to your doctor about the best way to control your blood sugar while you are pregnant. 
Posvetujte se z zdravnikom o tem, kako najbolje uravnavati krvni sladkor med nosečnostjo.
Frequency categories were defined according to very common (≥ 1/10), common (≥ 1/100 to ˂ 1/10), uncommon (≥ 1/1,000 to ˂ 1/100), rare ( 1/10,000 to < 1/1,000), very rare ( 1/100,000 to < 1/10,000) and not known (cannot be estimated from the available data). 
Kategorije pogostnosti so bile opredeljene kot: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki ( 1/10.000 do < 1/1.000), zelo redki ( 1/10.000 do < 1/10.000), neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
What Qtrilmet is and what it is used for 
Kaj je zdravilo Qtrilmet in za kaj ga uporabljamo
Your doctor may prescribe other medicines to lower the amount of sugar in your blood. 
Zdravnik vam lahko predpiše še druga zdravila za znižanje sladkorja v krvi.
The majority of patients in this study had a baseline HbA1c of > 8% (see Table 4). 
Večina bolnikov v tej študiji je imela izhodiščni HbA1c > 8 % (glejte preglednico 4).
Difference in HbA1c effect 
Razlika v učinku na HbA1c
Use in patients at risk for volume depletion, hypotension, and/or electrolyte imbalances 
Uporaba pri bolnikih s tveganjem za zmanjšanje volumna, hipotenzijo in/ali neravnovesje elektrolitov